Alexandria Real Estate Equities (ARE) Stock Overview
An S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 5/6 |
ARE Community Fair Values
Create NarrativeSee what 144 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
US$88
FV
42.1% undervalued intrinsic discount274
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
Alexandria Real Estate Equities, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$50.94 |
| 52 Week High | US$88.24 |
| 52 Week Low | US$39.41 |
| Beta | 1.18 |
| 1 Month Change | -7.75% |
| 3 Month Change | 11.81% |
| 1 Year Change | -38.02% |
| 3 Year Change | -59.73% |
| 5 Year Change | -74.70% |
| Change since IPO | 142.57% |
Recent News & Updates
Seeking Alpha • Jul 24
Alexandria Real Estate: The Uncertainty Is Real, But The Discount Has Gone Too Far
Summary Alexandria Real Estate Equities, Inc. faces severe leasing headwinds, especially from public biotech tenants, driving market pessimism and a >30% stock decline since mid-2025. ARE trades at a steep discount—P/FFO ~7x and P/B 0.5x—reflecting deep uncertainty, but its high-quality, irreplicable assets and strong tenant relationships remain valuable. Balance sheet strength is evident: $28.8B in real estate, $400M cash, and $12.5B debt. Also, the 2026 FFO guidance is $6.30–$6.50 per share. Despite ongoing sector challenges and low visibility, I rate ARE stock a Buy, as even a 'less bad' quarter could trigger sentiment recovery given the low expectations. Read the full article on Seeking Alpha
Narrative Update • Jul 22
ARE: Credit Facility Plans And Megacampus Leasing Will Shape Future Upside Potential
Analysts have reduced their price target for Alexandria Real Estate Equities to $51.0 from $55.5, citing updated assumptions that include a lower discount rate, a decline in revenue growth expectations, a modest improvement in profit margin, and a revised future P/E estimate. What's in the News Alexandria Real Estate Equities delivered a 427,000 rentable square feet research and development hub for Bristol Myers Squibb at its Campus Point by Alexandria Megacampus in San Diego, with the campus reported at 95.4% occupancy.
Narrative Update • Jul 08
ARE: Softer Margins And Widening Revenue Contraction Will Pressure Overvalued Shares
Analysts have trimmed their fair value estimate and implied price target for Alexandria Real Estate Equities from $50.00 to $42.00, reflecting slightly lower assumptions for revenue growth, profit margins, and future P/E multiples, along with a modest adjustment to the discount rate. What's in the News for Alexandria Real Estate Equities Alexandria Real Estate Equities, Inc.
Narrative Update • Jun 24
ARE: NYC Life Science Megacampus Leadership Will Support Future Upside
Analysts have adjusted their price target for Alexandria Real Estate Equities slightly higher to about $65.74 from roughly $65.00, reflecting updated assumptions for the discount rate, revenue growth, profit margin, and future P/E. What's in the News for Alexandria Real Estate Equities Alexandria Real Estate Equities highlighted its role as a leading owner, operator, and developer of collaborative life science and advanced technology megacampus ecosystems in premier clusters, with a focus on New York City life sciences.Recent updates
Seeking Alpha • Jul 24
Alexandria Real Estate: The Uncertainty Is Real, But The Discount Has Gone Too Far
Summary Alexandria Real Estate Equities, Inc. faces severe leasing headwinds, especially from public biotech tenants, driving market pessimism and a >30% stock decline since mid-2025. ARE trades at a steep discount—P/FFO ~7x and P/B 0.5x—reflecting deep uncertainty, but its high-quality, irreplicable assets and strong tenant relationships remain valuable. Balance sheet strength is evident: $28.8B in real estate, $400M cash, and $12.5B debt. Also, the 2026 FFO guidance is $6.30–$6.50 per share. Despite ongoing sector challenges and low visibility, I rate ARE stock a Buy, as even a 'less bad' quarter could trigger sentiment recovery given the low expectations. Read the full article on Seeking AlphaNarrative Update • Jul 22
ARE: Credit Facility Plans And Megacampus Leasing Will Shape Future Upside Potential
Analysts have reduced their price target for Alexandria Real Estate Equities to $51.0 from $55.5, citing updated assumptions that include a lower discount rate, a decline in revenue growth expectations, a modest improvement in profit margin, and a revised future P/E estimate. What's in the News Alexandria Real Estate Equities delivered a 427,000 rentable square feet research and development hub for Bristol Myers Squibb at its Campus Point by Alexandria Megacampus in San Diego, with the campus reported at 95.4% occupancy.Narrative Update • Jul 08
ARE: Softer Margins And Widening Revenue Contraction Will Pressure Overvalued Shares
Analysts have trimmed their fair value estimate and implied price target for Alexandria Real Estate Equities from $50.00 to $42.00, reflecting slightly lower assumptions for revenue growth, profit margins, and future P/E multiples, along with a modest adjustment to the discount rate. What's in the News for Alexandria Real Estate Equities Alexandria Real Estate Equities, Inc.Narrative Update • Jun 24
ARE: NYC Life Science Megacampus Leadership Will Support Future Upside
Analysts have adjusted their price target for Alexandria Real Estate Equities slightly higher to about $65.74 from roughly $65.00, reflecting updated assumptions for the discount rate, revenue growth, profit margin, and future P/E. What's in the News for Alexandria Real Estate Equities Alexandria Real Estate Equities highlighted its role as a leading owner, operator, and developer of collaborative life science and advanced technology megacampus ecosystems in premier clusters, with a focus on New York City life sciences.Narrative Update • Jun 05
ARE: Balance Sheet Repositioning And Governance Shift Will Support Future Upside
Analysts have trimmed their price target for Alexandria Real Estate Equities to $64.99 from $67.89. This reflects updated assumptions for a slightly lower discount rate, modestly slower revenue growth, a small improvement in profit margin, and a reduced future P/E estimate.Narrative Update • May 17
ARE: Governance Shift And Margin Outlook Will Support Future Upside Potential
Analysts have trimmed their price target for Alexandria Real Estate Equities by a little over $2 per share, citing updated assumptions that reflect a slightly higher discount rate, softer revenue expectations, and a modestly stronger profit margin outlook, which together feed into a recalibrated future P/E estimate. What's in the News On March 31, 2026, Alexandria Real Estate Equities filed Articles Supplementary in Maryland to opt out of Section 3-804(a) of the Maryland General Corporation Law, removing the statutory requirement for a two thirds stockholder vote to remove directors (Key Developments).Narrative Update • May 02
ARE: Simple Majority Governance Change Will Support Future Upside Potential
Analysts have trimmed their price target on Alexandria Real Estate Equities to $55.50 from $57.86, citing updated assumptions that include a slightly higher discount rate, a smaller projected revenue decline, a modestly higher profit margin, and a lower future P/E multiple. What's in the News On March 31, 2026, Alexandria Real Estate Equities filed Articles Supplementary in Maryland to opt out of Section 3-804(a) of the Maryland General Corporation Law, which had required at least a two thirds stockholder vote to remove directors (Key Developments).Narrative Update • Apr 18
ARE: Simple Majority Governance Shift And Impairment Reset Will Drive Future Upside
Analysts have reduced their price target on Alexandria Real Estate Equities by about $1, reflecting slightly higher assumed P/E ratios as well as more cautious views on revenue growth and profit margins in their updated models. What's in the News Alexandria Real Estate Equities filed Articles Supplementary in Maryland, effective March 31, 2026, opting out of the Maryland General Corporation Law Section 3-804(a) two-thirds voting requirement for director removal.Narrative Update • Apr 04
ARE: Governance Shift And Impairment Reset Will Shape Future Upside Potential
Analysts have trimmed their price target on Alexandria Real Estate Equities by about $1.36. This reflects updated views on fair value, profit margins and the appropriate discount rate for the shares.Narrative Update • Mar 21
ARE: Large Impairments And Softer Margins Will Shape Fairly Valued Shares
Analysts have trimmed their price target on Alexandria Real Estate Equities to $50.00, reflecting updated views on a slightly higher discount rate, softer revenue growth and profit margin assumptions, and a higher future P/E multiple. What's in the News Reported real estate impairment of US$1.717b for the fourth quarter ended December 31, 2025, compared with US$186.564m a year earlier (company disclosure).Narrative Update • Mar 06
ARE: Share Repurchases And Margin Recovery Will Support Future Upside Potential
Analysts have revised their price target on Alexandria Real Estate Equities to $70.00 from $82.97, citing updated assumptions around the discount rate, revenue trends, profit margin, and future P/E expectations. What's in the News Reported real estate impairments of US$1.717b for Q4 2025, compared with US$186.564m in the same quarter a year earlier, highlighting a large adjustment to property values (Key Developments).Narrative Update • Feb 20
ARE: Buyback And Dividend Reset Will Shape Future Upside Potential
Analysts have lifted their price target on Alexandria Real Estate Equities to $60.07 from $57.46, reflecting updated views on its fair value, discount rate, expected revenue contraction, profit margins, and future P/E assumptions. What's in the News Reported real estate impairments of approximately US$1.72b for the fourth quarter of 2025, compared with US$186.56m a year earlier (company filing).Narrative Update • Feb 06
ARE: Large Impairments And Dividend Cut Will Pressure Future Share Performance
Analysts have reduced their price target on Alexandria Real Estate Equities from US$71.00 to US$50.00, citing updated views on revenue contraction, higher discount rates and a lower future P/E multiple, partially offset by expectations for a higher profit margin. What's in the News Reported real estate impairments of approximately US$1.72b for the fourth quarter of 2025, compared with about US$186.56m a year earlier, highlighting a very large write down of property values.Narrative Update • Jan 23
ARE: Dividend Cut And Buyback Will Shape Future Risk Reward Balance
Analysts have slightly trimmed their price target for Alexandria Real Estate Equities, with fair value edging from US$58.33 to about US$57.46, citing updated assumptions for discount rates, revenue growth, profit margins near 23%, and a much lower future P/E estimate. What's in the News The Board of Directors authorized a share repurchase plan on December 5, 2025, allowing the company to buy back its common stock (Key Developments).Narrative Update • Jan 09
ARE: Share Repurchases And Dividend Reset Will Support Future Upside Potential
Analysts have cut their price target on Alexandria Real Estate Equities from about US$136.20 to about US$82.97, citing more cautious assumptions on revenue trends, margins, discount rate, and a much higher implied future P/E multiple. What's in the News The board authorizes a new share repurchase program of up to US$500 million, to be funded on a leverage neutral basis using operating cash after dividends plus proceeds from real estate sales and joint ventures, with authorization running through December 31, 2026 (company announcement).Narrative Update • Dec 25
ARE: Dividend Reset And Buyback Will Drive Long Term Upside Potential
Analysts have trimmed their price target on Alexandria Real Estate Equities by approximately 8 percent to around 58 dollars per share, citing softer revenue growth expectations, sharply lower projected profit margins, and a modestly reduced discount rate. Together, these factors point to a lower fair value despite elevated future valuation multiples.Narrative Update • Dec 11
ARE Dividend Reset And Buyback Will Support Long Term Recovery
Analysts have trimmed their price target for Alexandria Real Estate Equities by roughly 8 percent to about $63 per share, citing higher perceived risk, weaker projected revenue growth, and sharply compressed profit margins. Together, these factors are seen as warranting a lower fair value multiple.Narrative Update • Nov 27
ARE: Biotech Campus Expansion Will Drive Recovery Following Impairment Losses
Analysts have lowered their price target for Alexandria Real Estate Equities from $77.85 to $68.50. This decision is based on revised assessments of revenue growth and updated discount rate assumptions.Narrative Update • Nov 11
ARE: Expected Revenue Decline Will Be Offset By Biotech Expansion Momentum
Analysts have lowered their price target for Alexandria Real Estate Equities from $96.07 to $77.85. They cite a higher discount rate and anticipated revenue declines as primary factors in their revised outlook.Narrative Update • Oct 28
Share Repurchase and Expansion Will Support Long-Term Prospects Amid Earnings Update
Analysts have slightly lowered their price target for Alexandria Real Estate Equities, setting it at $96.07 from the previous $97.50. This adjustment is based on updated projections for revenue growth and profit margins.Narrative Update • Sep 16
Rising Healthcare R&D And Aging Demographics Will Support Future Success
With both the future P/E ratio and discount rate remaining nearly flat, the consensus analyst price target for Alexandria Real Estate Equities saw only a marginal increase from $96.42 to $97.50. What's in the News Alexandria Real Estate Equities completed the repurchase of 2,648,569 shares (1.53% of shares outstanding) for $258.25 million under its previously announced buyback program.Narrative Update • Aug 27
Rising Healthcare R&D And Aging Demographics Will Support Future Success
The consensus price target for Alexandria Real Estate Equities has been revised downward to $96.42, reflecting reduced estimates for both revenue growth and net profit margin. What's in the News No additional shares were repurchased from April to July 2025; the company has completed 2,648,569 share buybacks (1.53% of shares) for $258.25 million under its December 2024 announcement.Seeking Alpha • Apr 29
Alexandria Real Estate: Bonds Not Buying The Bear Thesis
Summary Alexandria Real Estate Equities delivered a Q1 2025 AFFO beat. The market tanked it further on the news. We look at the headwinds and tell you how we would play it. Read the full article on Seeking AlphaSeeking Alpha • Mar 25
Why Alexandria Is One Of The Best REITs To Buy Today
Summary Alexandria Real Estate has become a battleground stock. But it shouldn't be. This is a blue-chip REIT that's dealing with a temporary crisis. As its growth accelerates, I expect up to 50% upside as Alexandria reprices at a more reasonable valuation multiple. Read the full article on Seeking AlphaSeeking Alpha • Feb 22
Alexandria Real Estate: Expanding My Position Before Bears Turn Into Bulls
Summary Alexandria Real Estate has experienced a 50% drop in share price, but its high-quality life science assets and strong tenant base suggest this decline is unreasonable. There are risks due to a (current) oversupply in this sector, but a flight to quality should protect ARE going forward. With a well-covered dividend and prudent capital allocation, including buybacks, my conservative analysis warrants at least a $130 share price (+36%). Read the full article on Seeking AlphaSeeking Alpha • Jan 29
Alexandria Real Estate: Debunking The Bear Thesis
Summary Alexandria Real Estate is a battleground stock. It is today heavily discounted because of what we believe to be temporary issues. We debunk the bear thesis and explain why we are buying the stock. Read the full article on Seeking AlphaSeeking Alpha • Dec 30
Alexandria Real Estate: You Just Got Litt Up!
Summary Alexandria Real Estate's bull thesis was flawed. FFO estimates for ARE have dropped 20% over the last 18 months. The key bear fodder came from the REIT's 2025 guidance. One man got it right, really right. Read the full article on Seeking AlphaSeeking Alpha • Dec 17
Alexandria Real Estate: Excellent Countertrend Play On Multi-Year Big Tech Bust
Summary Alexandria RE is significantly undervalued compared to other U.S. equities, presenting a buy opportunity for contrarian investors. Historical performance during the Dotcom technology bust period suggests ARE could see robust gains years into the future, from countertrend capital flows toward value and income ideas. ARE's balance sheet is strong with low fixed-rate debt and operations stable with mostly pharmaceutical tenants, making it a safer investment amid potential market volatility. Read the full article on Seeking AlphaSeeking Alpha • Nov 16
Alexandria Real Estate: Buy The Dip And Start The DRIP
Summary Dividend reinvestment in high-quality stocks at below-average valuations like Alexandria Real Estate can result in potentially strong total returns. ARE's focus on mega campuses in innovation clusters results in sticky tenant relationships, robust leasing activity, and stable occupancy levels. ARE carries a strong balance sheet, attractive 4.9% dividend yield, and significant development pipeline, positioning it for solid future growth. Read the full article on Seeking AlphaSeeking Alpha • Oct 23
Alexandria Real Estate: Q3 Results Reinforce Bullish View
Summary Alexandria Real Estate Equities remains a strong buy due to its strategic mega campuses, high occupancy rates, and robust rental collections. Alexandria Real Estate reported solid earnings with 11% revenue growth and strong FFO, supported by high leasing volumes and investment-grade tenants. ARE stock's valuation is attractive, trading at 12.5 times expected FFO, with potential for multiple expansion and a 4.3% dividend yield. Risks include elevated interest rates and uncertain market multiples, but Alexandria's fixed-rate debt and strong fundamentals mitigate these concerns. Read the full article on Seeking AlphaShareholder Returns
| ARE | US Health Care REITs | US Market | |
|---|---|---|---|
| 7D | 1.4% | 3.2% | -1.1% |
| 1Y | -38.0% | 42.9% | 15.1% |
Return vs Industry: ARE underperformed the US Health Care REITs industry which returned 42.9% over the past year.
Return vs Market: ARE underperformed the US Market which returned 15.1% over the past year.
Price Volatility
| ARE volatility | |
|---|---|
| ARE Average Weekly Movement | 6.9% |
| Health Care REITs Industry Average Movement | 4.0% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ARE has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: ARE's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 514 | Peter Moglia | www.are.com |
Alexandria Real Estate Equities, Inc., an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Alexandria Real Estate Equities, Inc. Fundamentals Summary
| ARE fundamental statistics | |
|---|---|
| Market cap | US$8.88b |
| Earnings (TTM) | -US$1.07b |
| Revenue (TTM) | US$2.93b |
3.0x
P/S Ratio-8.3x
P/E RatioIs ARE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARE income statement (TTM) | |
|---|---|
| Revenue | US$2.93b |
| Cost of Revenue | US$920.35m |
| Gross Profit | US$2.01b |
| Other Expenses | US$3.08b |
| Earnings | -US$1.07b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 03, 2026
| Earnings per share (EPS) | -6.13 |
| Gross Margin | 68.59% |
| Net Profit Margin | -36.43% |
| Debt/Equity Ratio | 64.7% |
How did ARE perform over the long term?
See historical performance and comparisonDividends
9.2%
Current Dividend Yield48%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/26 02:21 |
| End of Day Share Price | 2026/07/24 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alexandria Real Estate Equities, Inc. is covered by 29 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wesley Golladay | Baird |
| David Rodgers | Baird |
| Ross Smotrich | Barclays |